1. The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
   Yuanbing Wu et al, 2017, Translational Research CrossRef
2. Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells.
   Chuangyu Wen et al, 2015, Int. J. Oncol. CrossRef
3. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling
   Zejun Fang et al, 2017, Cancer Letters CrossRef
4. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies
   Sandra Iurescia et al, 2018, Front. Immunol. CrossRef
5. DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications
   Mohammad Mirza-Aghazadeh-Attari et al, 2018, DNA Repair CrossRef
6. Ziyuglycoside II induces caspases-dependent and caspases-independent apoptosis in human colon cancer cells
   Khaliunaa Lkhagvasuren et al, 2019, Toxicology in Vitro CrossRef
7. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
   Gaetano Marverti, 0 CrossRef
8. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG‐I‐like receptors
   Maria Batool et al, 2021, Med Res Rev CrossRef
9. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment.
   Shamin Azwar et al, 2021, Biology (Basel) CrossRef
10. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest.
    Michael Aschner, 0 CrossRef
11. Thiolated pectin-chitosan composites: Potential mucoadhesive drug delivery system with selective cytotoxicity towards colorectal cancer
    Theodore Ebenezer Leonard et al, 2023, International Journal of Biological Macromolecules CrossRef